These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2500343)

  • 41. A phase III randomized study of 5-fluorouracil and cisplatin versus 5-fluorouracil, doxorubicin, and mitomycin C versus 5-fluorouracil alone in the treatment of advanced gastric cancer.
    Kim NK; Park YS; Heo DS; Suh C; Kim SY; Park KC; Kang YK; Shin DB; Kim HT; Kim HJ
    Cancer; 1993 Jun; 71(12):3813-8. PubMed ID: 8508349
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group study.
    Forastiere AA; Metch B; Schuller DE; Ensley JF; Hutchins LF; Triozzi P; Kish JA; McClure S; VonFeldt E; Williamson SK
    J Clin Oncol; 1992 Aug; 10(8):1245-51. PubMed ID: 1634913
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Phase II study of cisplatin and continuous-infusion 5-fluorouracil and bleomycin for recurrent and metastatic head and neck squamous-cell carcinoma.
    Tellez-Bernal E; Belehradek M; Recondo G; Cvitkovic E; Leridant AM; Vericel R; Armand JP
    Am J Clin Oncol; 1990 Oct; 13(5):452-4. PubMed ID: 1699403
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A phase II study of continuous infusion 5-fluorouracil and leucovorin with weekly cisplatin in metastatic colorectal carcinoma.
    Grem JL; McAtee N; Balis F; Murphy R; Venzon D; Kramer B; Goldspiel B; Begley M; Allegra CJ
    Cancer; 1993 Aug; 72(3):663-8. PubMed ID: 8334622
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Vinorelbine, cisplatin, and 5-fluorouracil as initial treatment for previously untreated, unresectable squamous cell carcinoma of the head and neck: results of a phase II multicenter study.
    Gebbia V; Mantovani G; Farris A; Agostara B; Desogus A; Curreli L; Moschella F; Di Gregorio C; Bajetta E; Gebbia N
    Cancer; 1997 Apr; 79(7):1394-400. PubMed ID: 9083162
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hexamethylmelamine-CAF (cyclophosphamide, methotrexate, and 5-FU) and cisplatin-CAF in refractory ovarian cancer.
    Sessa C; D'Incalci M; Valente I; Bolis G; Colombo N; Mangioni C
    Cancer Treat Rep; 1982 May; 66(5):1233-4. PubMed ID: 6805951
    [No Abstract]   [Full Text] [Related]  

  • 47. Advanced ovarian cancer: long-term results of treatment with intensive cisplatin-based chemotherapy of brief duration.
    Hainsworth JD; Grosh WW; Burnett LS; Jones HW; Wolff SN; Greco FA
    Ann Intern Med; 1988 Feb; 108(2):165-70. PubMed ID: 3124679
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A phase I study of paclitaxel and altretamine as second-line therapy to cisplatin regimens for ovarian cancer.
    Olver I; Davy M; Lüftner D; Park SH; Egorin M; Ellis A; Webster L
    Cancer Chemother Pharmacol; 2001 Aug; 48(2):109-14. PubMed ID: 11561776
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fluorouracil (F), Adriamycin (A), and cisplatin (P) (FAP): combination chemotherapy of advanced esophageal carcinoma.
    Gisselbrecht C; Calvo F; Mignot L; Pujade E; Bouvry M; Danne O; Belpomme D; Marty M
    Cancer; 1983 Sep; 52(6):974-7. PubMed ID: 6683991
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cisplatin, fluorouracil, and high-dose leucovorin for recurrent or metastatic head and neck cancer.
    Vokes EE; Choi KE; Schilsky RL; Moran WJ; Guarnieri CM; Weichselbaum RR; Panje WR
    J Clin Oncol; 1988 Apr; 6(4):618-26. PubMed ID: 3258629
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 5-Fluorouracil, leucovorin, hydroxyurea, and escalating doses of continuous-infusion cisplatin with concomitant radiotherapy: a clinical and pharmacologic study.
    Vokes EE; Moormeier JA; Ratain MJ; Egorin MJ; Haraf DJ; Mick R; Weichselbaum RR
    Cancer Chemother Pharmacol; 1992; 29(3):178-84. PubMed ID: 1733549
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Chronotherapy with high dose carboplatin, 5-fluorouracil and leucovorin in advanced colorectal carcinoma].
    Popov I; Jelić S; Radosavljević D; Nikolić-Tomasević A
    Srp Arh Celok Lek; 1998; 126(9-10):355-61. PubMed ID: 9863407
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Low-dose docetaxel/cisplatin - leucovorin and 46 hour infusional fluorouracil in metastatic gastric carcinoma.
    Alici S; Buyukberber S; Alkis N; Benekli M; Ozkan M; Bilici A; Demirci U; Karaca H; Arpaci E; Gumus M; Altunbas M; Dane F; Turk HM;
    Asian Pac J Cancer Prev; 2013; 14(1):423-7. PubMed ID: 23534766
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cisplatin and 5-fluorouracil combination chemotherapy in advanced and/or metastatic colorectal carcinoma: a phase II study.
    Galligioni E; Canobbio L; Figoli F; Fassio T; Frustaci S; Crivellari D; Vaccher E; Lo Re G; Gasparini G; Veronesi A
    Eur J Cancer Clin Oncol; 1987 Jun; 23(6):657-61. PubMed ID: 3653187
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Doxorubicin, streptozocin, and 5-fluorouracil chemotherapy for patients with metastatic islet-cell carcinoma.
    Rivera E; Ajani JA
    Am J Clin Oncol; 1998 Feb; 21(1):36-8. PubMed ID: 9499254
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment of patients with advanced gastric carcinoma with a 5-fluorouracil-based or a cisplatin-based regimen: two parallel randomized phase II studies.
    Barone C; Corsi DC; Pozzo C; Cassano A; Fontana T; Noviello MR; Landriscina M; Colloca G; Astone A
    Cancer; 1998 Apr; 82(8):1460-7. PubMed ID: 9554521
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lack of value for cisplatin added to mitomycin-doxorubicin combination chemotherapy for carcinoma of unknown primary site. A randomized trial.
    Eagan RT; Therneau TM; Rubin J; Long HJ; Schutt AJ
    Am J Clin Oncol; 1987 Feb; 10(1):82-5. PubMed ID: 3548315
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Taxane-based chemotherapy for patients with carcinoma of unknown primary site.
    Greco FA; Gray J; Burris HA; Erland JB; Morrissey LH; Hainsworth JD
    Cancer J; 2001; 7(3):203-12. PubMed ID: 11419028
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Controlled phase III clinical study of 4-epi-doxorubicin + 5-fluorouracil versus 5-fluorouracil alone in metastatic gastric and rectosigmoid cancer.
    Kolarić K; Potrebica V; Stanovnik M
    Oncology; 1986; 43(2):73-7. PubMed ID: 3513075
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Chemotherapy versus chemoimmunotherapy (CAF v CAFVP v CMF each +/- MER) for metastatic carcinoma of the breast: a CALGB study. Cancer and Leukemia Group B.
    Aisner J; Weinberg V; Perloff M; Weiss R; Perry M; Korzun A; Ginsberg S; Holland JF
    J Clin Oncol; 1987 Oct; 5(10):1523-33. PubMed ID: 3655855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.